Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|11|1147-1157

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.11, 2017-05, pp. : 1147-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2188-2205

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic applications of farnesoid X receptor (FXR) modulators

By Pellicciari Roberto   Gioiello Antimo   Costantino Gabriele  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite

The farnesoid X receptor: a novel drug target?

By Claudel Thierry   Sturm Ekkehard   Kuipers Folkert   Staels Bart  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1135-1148

Informa Healthcare

Access to resources Recommend Favorite

Editorial: (Thematic Issue: Medicinal Chemistry of Farnesoid X Receptor (FXR) Modulators: The-State-of-the-Art)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2127-2128

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2129-2142

Bentham Science Publishers

Access to resources Recommend Favorite